'To evaluate the frequency and pattern of pulmonary vascular abnormalities in the year following COVID-19'
Methods
Study of 79 patients remaining symptomatic >6 months after hospitalization for SARS-CoV-2 pneumonia who had been evaluated with dual-energy CT angiography
(The word 'pneumonia' here is a misleading, but it's what most researchers call it, so let's go with it.)
Results
Chronic (persistent) clots in lung blood vessels in 5%
Acute (recent) clots in lung blood vessels in 2.5%
This doesn't sound like much but it only refers to the clots that are visible. It is much greater than would be expected following a respiratory viral pneumonia.
Lung perfusion was abnormal in 87.4%
This is massive!
It means the blood vessels of the lungs remain abnormal in these people (hospitalized during acute CV)
Note: Conventional CT scans alone don't show perfusion defects. The study used Dual-Energy CT (also called spectral CT)
Here is a Dual-Energy CT scan from the study (at 32 weeks post infection)
On the left is the conventional CT element.
It looks normal!
On the right is the perfusion element of the same scan which shows an area of reduced perfusion.
Another Dual-Energy CT (at 24 weeks)
The conventional CT element shows an area of increased density near the edge of the lung.
Usually we would think this is due to inflammation of the small airways. But the perfusion element of the scan shows it is due to increased perfusion.
So, the perfusion abnormalities can be due to either reduced or increased perfusion.
This is also the case in patients with acute #COVID-19.
It shows a feature that is highly specific to acute phase COVID-19 lung disease. It is called 'vascular tree-in-bud'. It is a sign of disease of the small blood vessels in the lungs
This study found that this sign persists
This is important because vascular tree-in-bud is visible on the conventional CT element of the scan. However, without the perfusion element of the scan this would very easily be mistaken for inflammation in small airways by a radiologist not aware it is a feature of COVID AND LC
The study suggests this phenomenon is due to 'aberrant angiogenesis' (abnormal formation/repair of blood vessels)
The study suggests the perfusion defects are due to unresolved microthombi (clots) within the pulmonary capillaries (the smallest of all blood vessels).
This is exactly what is found on autopsy studies in those who die of acute #COVID! See Carsana et al pubmed.ncbi.nlm.nih.gov/32526193/
Conclusion
The study shows 'numerous abnormalities at the level of lung microcirculation in the year following hospitalization'
AND ...
Conclusion
'Our results suggest the complementarity between HRCT and spectral imaging for proper understanding of post COVID-19 lung sequelae'
This means that all conventional imaging (such as CT or CTPA) can be misleadingly normal post acute COVID.
It aligns with other studies which suggest that some form of perfusion imaging is probably best. See this review ... ncbi.nlm.nih.gov/pmc/articles/P…
I want this post to be informative to doctors who have patients suffering following #COVID-19.
Not only is #LongCOVID real. It is visible!
Conventional imaging won't be abnormal in most, even those who were hospitalized with acute COVID-19.
Only some features are occasionally visible on conventional CT and the radiologist would need to be very alert.
Although treatment options are still being investigated, some are thought to be beneficial. (#teamclots)
Post-acute symptoms should be taken seriously. Imaging may not be informative, but this is not the patient's fault - the medical imaging is letting us and them down
Rule #1
If your patient has persistent symptoms post acute COVID, then please believe them
Rule #2
Imaging has a limited role and normal imaging should not be taken to mean there is no problem
Rule #3
Perfusion scanning is probably best for those with persistent respiratory symptoms
Rule #4
Believing your patient is more important than imaging
(It's the old adage: Treat your patient, not the imaging!)
Rule #5
COVID-19 is NOT pneumonia!
(Although this paper calls the acute phase disease a 'pneumonia', this is misleading. The disease is a pulmonary vasculopathy, a disease of the lung blood vessels.)
Rule #6
Acute #COVID-19 and #LongCOVID are the same disease. Some get better, some don't.
(The lung damage shows identical features in both phases of the disease)
Thanks for reading!
• • •
Missing some Tweet in this thread? You can try to
force a refresh
The COVID-19 Pathway: A Proposed Oral-Vascular-Pulmonary Route Of SARS-CoV-2 Infection And The Importance Of Oral Healthcare Measures bit.ly/36uEwar
What has changed since then?
Please see this thread ...
The world has caught up and #COVID-19 is now widely understood to be a vascular disease. This includes the severe acute lung disease which itself is not a respiratory 'pneumonia' but a 'vasculopathy'
See this explanation of the imaging (Nov 2020)
Prothrombotic inflammatory processes are now understood to be central to the disease. We used a first principles model of direct viral interaction with endothelial ACE2 (see this short video) but clotting processes are more complex than we describe.
Important news about XXB1.5 pointing out that infection is more via the ACE2 receptor than previous Omicron variants.
But … the mouth is not mentioned as an important site of infection…. cambridgeindependent.co.uk/news/fast-spre…
A thread … 1/
2/ Minor salivary glands over the surface of the tongue, inner surface of the lips, the fauces and soft palate are highly susceptible to infection and replication. Epithelial cells in these areas express the ACE2 receptor. nature.com/articles/s4159…
3/ The mouth can be considered a viral factory with viral entry into saliva in high quantity - 100 million per ml (equivalent to half a billion viruses in a single 5 ml teaspoon). ncbi.nlm.nih.gov/pmc/articles/P…
Based on imaging of the lung disease post acute #COVID/#longCOVID there might be 2 things going on
1- fibrosis due to the acute phase lung injury
2 - endothelial damage - not related to the acute disease
The literature doesn't yet reflect the complexity but getting there ...
In those with respiratory symptoms at 3 months - on Dual Energy CT scans
- 5% have visible clots in lung arteries
- 65% have microangiopathy (disease of small blood vessels of the lungs)
Imaging which assesses perfusion (blood supply) to the lungs is likely to be most helpful post-COVID, not conventional imaging (eg X-ray or CT - other than Dual Energy CT).
- 'such imaging should be embedded in routine post-COVID-19 follow-up pathways'